Trial
NCT00601289
Temozolomide in Treating Patients With Invasive Pituitary Tumors
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
—
Condition
Brain and Central Nervous System Tumors
Intervention
temozolomide
Why stopped
funding term ended
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-31